| Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool: BM Jobin Jose , Rajesh Kumar ,Seetha Harilal ,Githa Elizabeth Mathew , Della ... : Environmental Science and Pollution Research, Nanotechnology …, 2020 | 245* | 2020 |
| Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives S Harilal, J Jose, DGT Parambi, R Kumar, GE Mathew, MS Uddin, H Kim, ... Journal of Pharmacy and Pharmacology 71 (9), 1370-1383, 2019 | 154 | 2019 |
| Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases B Mathew, DGT Parambi, GE Mathew, MS Uddin, ST Inasu, H Kim, ... Archiv der Pharmazie 352 (11), 1900177, 2019 | 124 | 2019 |
| GC-MS analysis of phytochemical compounds present in the rhizomes of Nervilia aragoana GAUD della grace thomas, aneesh t.p Asian Journal of Pharmaceutical and Clinical Research 6, 68-74, 2013 | 123 | 2013 |
| Revisiting the blood brain barrier: A hard nut to cracking the transportation of drug molecules : BM Seetha Harilal, Jobin Jose, Della Grace Thomas Parambi, RajeshKumar ... Brain research bulletin, 160, 121-140, 2020 | 108 | 2020 |
| Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work: BM RajeshKumar, Seetha Harilal, Sheeba Varghese Gupta, JobinJose, Della ... European Journal of Medicinal Chemistry 182, 111602, 2019 | 76 | 2019 |
| Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors, BM Della Grace Thomas Parambi, Jong MinOh,Seung CheolBaek, Jae PilLee, Anna ... Bio organic chemistry 93, 103335, 2019 | 61* | 2019 |
| potent and highly selective dual- targeting monoamine oxidase-B inhibitors: fluorinated chalcones of morpholine versus imidazole. DGTP BIJO MATHEW, SEUNG C BEAK Archiv Der Pharmazie 352 (4), 1800309, 2019 | 57 | 2019 |
| Gene therapy approach with an emphasis on growth factors: theoretical and clinical outcomes in neurodegenerative diseases DGT Parambi, KS Alharbi, R Kumar, S Harilal, GES Batiha, ... Molecular Neurobiology, 1-43, 2022 | 53 | 2022 |
| Perspective design of chalcones for the management of CNS disorders: a mini-review B Mathew, DGT Parambi, VS Sivasankarapillai, MS Uddin, J Suresh, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2019 | 51 | 2019 |
| Piperazine-substituted chalcones: A new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders B Mathew, JM Oh, RS Baty, GES Batiha, DGT Parambi, N Gambacorta, ... Environmental Science and Pollution Research 28, 38855-38866, 2021 | 45 | 2021 |
| Selected aryl thiosemicarbazones as new class of multi-targeted monoamine oxidase inhibitors GKKH Bijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, Jae Pil Lee ... med chem communications, 2018 | 43* | 2018 |
| Development of bromo-and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease MA Abdelgawad, JM Oh, DGT Parambi, S Kumar, A Musa, MM Ghoneim, ... Journal of Molecular Structure 1266, 133545, 2022 | 41 | 2022 |
| Design, synthesis and biological evaluation of new HDAC1 and HDAC2 inhibitors endowed with ligustrazine as a novel cap moiety MM Al-Sanea, L Gotina, MFA Mohamed, D Grace Thomas Parambi, ... Drug design, development and therapy, 497-508, 2020 | 41 | 2020 |
| Novel phenolic compounds as potential dual EGFR and COX-2 inhibitors: Design, semisynthesis, in vitro biological evaluation and in silico Insights MA Abdelgawad, A Musa, AH Almalki, SI Alzarea, EM Mostafa, ... Drug design, development and therapy, 2325-2337, 2021 | 39 | 2021 |
| New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study MM Al-Sanea, A Hamdi, AAB Mohamed, HW El-Shafey, M Moustafa, ... Journal of enzyme inhibition and medicinal chemistry 38 (1), 2166036, 2023 | 31 | 2023 |
| Exploring the therapeutic potentials of highly selective oxygenated chalcone based MAO-B inhibitors in a haloperidol-induced murine model of Parkinson’s disease DGT Parambi, U Saleem, MA Shah, F Anwar, B Ahmad, A Manzar, A Itzaz, ... Neurochemical research 45, 2786-2799, 2020 | 31 | 2020 |
| A validated stability indicating HPLC method for the determination of Valsartan in tablet dosage forms M Mathew, V Ganesan Journal of Applied Pharmaceutical Science, 97-99, 2011 | 29 | 2011 |
| Phytochemical Screening and antimicrobial investigation of Typha angustifolia Linn JA Varghese Alexeyena, Gavani Usha,Abraham suja,DGT Parambi international Journal of Chemical Sciences 7 (3), 1905-1910, 2009 | 29 | 2009 |
| The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico … A Musa, SK Ihmaid, DL Hughes, MA Said, HS Abulkhair, AH El-Ghorab, ... Journal of Biomolecular Structure and Dynamics 41 (21), 12411-12425, 2023 | 24 | 2023 |
